|
BR0116468A
(pt)
*
|
2000-12-08 |
2004-06-29 |
Ortho Mcneil Pharm Inc |
Compostos de pirrolina substituìda por indazolila como inibidores de cinase
|
|
SE0200979D0
(sv)
*
|
2002-03-28 |
2002-03-28 |
Astrazeneca Ab |
New compounds
|
|
SE0302546D0
(sv)
*
|
2003-09-24 |
2003-09-24 |
Astrazeneca Ab |
New compounds
|
|
CA2485527A1
(en)
*
|
2002-05-08 |
2003-11-20 |
Janssen Pharmaceutica N.V. |
Substituted pyrroline kinase inhibitors
|
|
ES2312785T3
(es)
*
|
2002-06-05 |
2009-03-01 |
Janssen Pharmaceutica Nv |
Pirrolinas sustituidas utiles como inhibidores de quinasa.
|
|
CA2393720C
(en)
*
|
2002-07-12 |
2010-09-14 |
Eli Lilly And Company |
Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
|
|
AU2002951253A0
(en)
*
|
2002-09-06 |
2002-09-19 |
Medvet Science Pty. Ltd. |
A method of modulating cellular activity
|
|
JP2006521386A
(ja)
*
|
2003-03-27 |
2006-09-21 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
キナーゼ阻害剤である置換ピロリン
|
|
US7439363B2
(en)
*
|
2003-06-13 |
2008-10-21 |
Janssen Parmaceutica N.V. |
Substituted indazoly(indoly)maleimide derivatives as kinase inhibitors
|
|
US20080050314A1
(en)
*
|
2004-02-26 |
2008-02-28 |
Bayer Healthcare Ag |
Diagnostics and Therapeutics for Diseases Associated With Glycogen Synthase Kinase 3 Beta (Gsk3b)
|
|
WO2005095983A1
(en)
*
|
2004-03-04 |
2005-10-13 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with protein kinase c, gamma (prkcg)
|
|
RU2413511C2
(ru)
*
|
2004-04-08 |
2011-03-10 |
Новартис Аг |
Ингибиторы протеинкиназы с, предназначенные для лечения аутоиммунных заболеваний и отторжения трансплантата
|
|
US20070232658A1
(en)
*
|
2004-04-08 |
2007-10-04 |
Jurgen Wagner |
Protein Kinase C Inhibitors for the Treatment of Autoimmune Diseases and of Transplant Rejiction
|
|
CA2567377A1
(en)
*
|
2004-05-21 |
2006-03-09 |
The Texas A & M University System |
Inhibition of atherosclerosis by diindolylmethane analogs
|
|
EP1662259A1
(en)
*
|
2004-11-25 |
2006-05-31 |
Cellzome Ag |
Use of Eph receptor inhibitors for the treatment of neurodegenerative diseases
|
|
US8017395B2
(en)
|
2004-12-17 |
2011-09-13 |
Lifescan, Inc. |
Seeding cells on porous supports
|
|
JP2009500297A
(ja)
*
|
2005-06-08 |
2009-01-08 |
セントカー・インコーポレーテツド |
眼の変性についての細胞療法
|
|
EP2246346B1
(en)
|
2005-07-11 |
2012-10-24 |
Novartis AG |
Indolylmaleimide derivatives as protein kinase inhibitors
|
|
EP2275096A3
(en)
|
2005-08-26 |
2011-07-13 |
Braincells, Inc. |
Neurogenesis via modulation of the muscarinic receptors
|
|
EP2258357A3
(en)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenesis with acetylcholinesterase inhibitor
|
|
WO2007041195A2
(en)
*
|
2005-09-29 |
2007-04-12 |
Janssen Pharmaceutica N.V. |
Macroheterocylic compounds as kinase inhibitors
|
|
WO2007047978A2
(en)
|
2005-10-21 |
2007-04-26 |
Braincells, Inc. |
Modulation of neurogenesis by pde inhibition
|
|
EP2314289A1
(en)
|
2005-10-31 |
2011-04-27 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
US20090324610A1
(en)
*
|
2006-04-25 |
2009-12-31 |
Kyushu Univeristy, National University Corporation |
Gene associated with arteriosclerotic disease, and use thereof
|
|
US8741643B2
(en)
*
|
2006-04-28 |
2014-06-03 |
Lifescan, Inc. |
Differentiation of pluripotent stem cells to definitive endoderm lineage
|
|
EP2021000A2
(en)
|
2006-05-09 |
2009-02-11 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
JP2008063278A
(ja)
*
|
2006-09-07 |
2008-03-21 |
Fujifilm Finechemicals Co Ltd |
1−ピリジン−4−イル−インドール類の製造方法
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
US9080145B2
(en)
*
|
2007-07-01 |
2015-07-14 |
Lifescan Corporation |
Single pluripotent stem cell culture
|
|
RU2473685C2
(ru)
|
2007-07-31 |
2013-01-27 |
Лайфскен, Инк. |
Дифференцировка человеческих эмбриональных стволовых клеток
|
|
CN107574142B
(zh)
|
2007-11-27 |
2021-07-06 |
生命扫描有限公司 |
人胚胎干细胞的分化
|
|
FR2927075A1
(fr)
*
|
2008-02-04 |
2009-08-07 |
Centre Nat Rech Scient |
Molecules comprenant un squelette bis-(heteroaryl)maleimide, et leur utilisation dans l'inhibition d'enzymes
|
|
BRPI0908033A2
(pt)
|
2008-02-21 |
2015-08-04 |
Centocor Ortho Biotech Inc |
Método placas de superfície modificada e composições para adesão, cultura e desprendimento de célula
|
|
US8623648B2
(en)
|
2008-04-24 |
2014-01-07 |
Janssen Biotech, Inc. |
Treatment of pluripotent cells
|
|
US20090291982A1
(en)
*
|
2008-05-22 |
2009-11-26 |
Astrazeneca Ab |
New Substituted Oxindole Derivative 352
|
|
CN108486040A
(zh)
*
|
2008-06-30 |
2018-09-04 |
詹森生物科技公司 |
多能干细胞的分化
|
|
CA2729121C
(en)
|
2008-06-30 |
2019-04-09 |
Centocor Ortho Biotech Inc. |
Differentiation of pluripotent stem cells
|
|
US20100028307A1
(en)
*
|
2008-07-31 |
2010-02-04 |
O'neil John J |
Pluripotent stem cell differentiation
|
|
JP2012507289A
(ja)
|
2008-10-31 |
2012-03-29 |
ヤンセン バイオテツク,インコーポレーテツド |
ヒト胚性幹細胞の膵内分泌系への分化
|
|
EP2346988B1
(en)
*
|
2008-10-31 |
2017-05-31 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells to the pancreatic endocrine lineage
|
|
MX2011005288A
(es)
|
2008-11-20 |
2011-06-01 |
Centocor Ortho Biotech Inc |
Celulas madre pluripotentes en microportadores.
|
|
CA2744227C
(en)
*
|
2008-11-20 |
2018-10-02 |
Centocor Ortho Biotech Inc. |
Methods and compositions for cell attachment and cultivation on planar substrates
|
|
US20100216805A1
(en)
|
2009-02-25 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
RU2540016C2
(ru)
|
2009-07-20 |
2015-01-27 |
Янссен Байотек, Инк. |
Дифференцировка эмбриональных стволовых клеток человека
|
|
EP2456858B1
(en)
|
2009-07-20 |
2018-08-29 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells
|
|
EP2456862A4
(en)
|
2009-07-20 |
2013-02-27 |
Janssen Biotech Inc |
DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS
|
|
PH12012500818A1
(en)
*
|
2009-10-29 |
2019-11-29 |
Janssen Biotech Inc |
Pluripotent stem cells
|
|
DK2516625T3
(da)
|
2009-12-23 |
2024-09-09 |
Janssen Biotech Inc |
Differentiering af humane embryonale stamceller
|
|
RU2664864C1
(ru)
*
|
2009-12-23 |
2018-08-23 |
Янссен Байотек, Инк. |
Способы увеличения экспрессии ngn3 и nkx6.1 в эндокринных клетках поджелудочной железы
|
|
AU2011223900A1
(en)
*
|
2010-03-01 |
2012-09-13 |
Janssen Biotech, Inc. |
Methods for purifying cells derived from pluripotent stem cells
|
|
AU2011250912A1
(en)
|
2010-05-12 |
2012-11-22 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells
|
|
KR101836850B1
(ko)
|
2010-08-31 |
2018-03-09 |
얀센 바이오테크 인코포레이티드 |
인간 배아 줄기 세포의 분화
|
|
CN103221536B
(zh)
|
2010-08-31 |
2016-08-31 |
詹森生物科技公司 |
人胚胎干细胞的分化
|
|
WO2012030540A2
(en)
|
2010-08-31 |
2012-03-08 |
Janssen Biotech, Inc. |
Differentiation of pluripotent stem cells
|
|
ES2387359B1
(es)
*
|
2011-02-25 |
2013-08-01 |
Consejo Superior De Investigaciones Científicas (Csic) |
Inhibidores de GSK-3 útiles en enfermedades neurodegenerativas, inflamatorias, cáncer, diabetes y en procesos regenerativos
|
|
RU2705001C2
(ru)
|
2011-12-22 |
2019-11-01 |
Янссен Байотек, Инк. |
Дифференцировка эмбриональных стволовых клеток человека в одногормональные инсулинположительные клетки
|
|
MX354775B
(es)
|
2012-03-07 |
2018-03-20 |
Janssen Biotech Inc |
Medios definidos para la expansion y el mantenimiento de celulas madre pluripotentes.
|
|
CN104334719B
(zh)
|
2012-06-08 |
2018-02-13 |
詹森生物科技公司 |
人胚胎干细胞向胰腺内分泌细胞的分化
|
|
KR102084561B1
(ko)
|
2012-12-31 |
2020-03-04 |
얀센 바이오테크 인코포레이티드 |
췌장 내분비 세포로의 분화를 위한 공기-액체 계면에서의 인간 배아 줄기세포의 배양
|
|
MX2015008578A
(es)
|
2012-12-31 |
2015-09-07 |
Janssen Biotech Inc |
Diferenciacion de celulas madre embrionarias humanas en celulas endocrinas pancreaticas mediante el uso de relugadores de hb9.
|
|
US10370644B2
(en)
|
2012-12-31 |
2019-08-06 |
Janssen Biotech, Inc. |
Method for making human pluripotent suspension cultures and cells derived therefrom
|
|
DK2938722T3
(da)
|
2012-12-31 |
2022-02-14 |
Janssen Biotech Inc |
Suspension og klyngedannelse af humane pluripotente celler til differentiering til endokrine pankreasceller
|
|
SG11201609473XA
(en)
|
2014-05-16 |
2016-12-29 |
Janssen Biotech Inc |
Use of small molecules to enhance mafa expression in pancreatic endocrine cells
|
|
WO2017180361A1
(en)
|
2016-04-14 |
2017-10-19 |
Janssen Biotech, Inc. |
Differentiation of pluripotent stem cells to intestinal midgut endoderm cells
|
|
CN105777751B
(zh)
*
|
2016-04-26 |
2018-12-11 |
浙江工业大学 |
一种双芳基马来酰亚胺类化合物及其药学上可接受的盐及其制备方法和应用
|
|
WO2020163812A1
(en)
|
2019-02-08 |
2020-08-13 |
Frequency Therapeutics, Inc. |
Valproic acid compounds and wnt agonists for treating ear disorders
|